Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 18, 2020
OSE Immunotherapeutics and Servier announced the execution of an amendment to the two-step global licensing option agreement for exclusive global rights to interleukin-7 receptor antagonist OSE-127.
read more
Protecting the health and safety of our staff and their families is of paramount concern to the U.S. Food and Drug Administration.
read more
Univercells has launched a contract development and manufacturing organization (CDMO), Exothera.
read more
The FDA issued a guidance for industry, investigators and institutional review boards conducting clinical trials during the coronavirus (COVID-19) pandemic.
read more
Biomerica has commenced shipping initial samples of its COVID-19 IgG/IgM Rapid Test.
read more
Altasciences have entered into an agreement with Amador Bioscience, a translational and consulting clinical research organization located in China and the U.S.
read more
BOQI announced its wholly-owned subsidiary, Chongqing Guanzan Technology has entered into a $19 million medical device purchase agreement with Shandong Forward Medical.
read more
USP is providing free technical assistance to developers of medical treatments such as antiviral drugs and vaccines that can support the public health response to the COVID-19 pandemic.
read more
The PBOA reports its member companies remain committed to serving patients by manufacturing effective, quality products for their customers, during this global health crisis, and report no material disruptions to their operations.
read more
FDA is issuing this guidance to provide a policy to help expand the availability and capability of non-invasive remote monitoring devices to facilitate patient monitoring while reducing patient and healthcare provider contact and exposure to COVID-19...
read more
Abbott announced the FDA has issued Emergency Use Authorization for the company's molecular test for novel coronavirus.
read more
CEL-SCI has signed a collaboration agreement with the University of Georgia’s Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy.
read more
The Medical CBRN Defense Consortium has released a RFI seeking solutions to combat the novel Coronavirus pandemic.
read more
Elligo Health Research is working with Verily to support the Project Baseline COVID-19 Program.
read more
CTK has launched two diagnostic tests for this virus, both a real time PCR based nucleic acid detection kit and a serological rapid screening test.
read more